LATEST NEWS

Uromedica at AUA 2021

Come visit Uromedica at Booth 431 in Las Vegas for the American Urological Association (AUA) meeting!

September 10, 2021

Image-empty-state.png

First Patients Enrolled in ACT Trial

First Patients Enrolled in Uromedica’s Adjustable Continence Therapy (ACT®) for Female Stress Urinary Incontinence (SUI) Trial

March 10, 2021

Image-empty-state.png

New ProACT Surgical Video

New surgical video for the ProACT Adjustable Continence Therapy for Men.

January 18, 2021

Image-empty-state.png

New ProACT Animation

New animation on the ProACT Adjustable Continence Therapy for Men procedure.

July 7, 2020

Image-empty-state.png

New ProACT Paper

New OUS ProACT Paper: What if artificial urinary sphincter is not possible? Feasibility and effectiveness of ProACT for patients with persistent stress urinary incontinence after radical prostatectomy treated by sling

April 6, 2020

Image-empty-state.png

ACT Clinical Trial

FDA Approval on the Protocol for the Clinical Investigation on the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence

January 23, 2020

Image-empty-state.png

ProACT receives French National Reimbursement

ProACT is now listed on the LPPR register and reimbursed in France.

December 24, 2019

Image-empty-state.png

New ProACT Paper

New USA ProACT Paper: Adjustable continence therapy (ProACT) for the treatment of male stress urinary incontinence: A systematic review and meta-analysis

August 20, 2019

Image-empty-state.png

New ProACT Paper

New USA ProACT Paper: Treatment with an adjustable long-term implant for post-prostatectomy stress incontinence: The ProACT™ pivotal trial.

September 3, 2018

Image-empty-state.png

First US Commercial Implant of ProACT

Uromedica Announces Successful First US Commercial Implant of ProACT™ Adjustable Continence Therapy for Men

November 2, 2017

Image-empty-state.png

Launch of ProACT and Reimbursement Coding

Uromedica Announces Launch of ProACT™ Adjustable Continence Therapy for Men with FDA Approval and Reimbursement Coding

July 11, 2017

Image-empty-state.png

French Randomized Trial Between ACT and AMS 800 AUS

First patients enrolled in French Randomized Trial Between Uromedica’s Adjustable Continence Therapy (ACT) and Boston Scientific’s AMS 800 Artificial Urinary Sphincter (AUS)

July 4, 2016

Image-empty-state.png

New ProACT Paper

New ProACT Paper in Urology: Maximum Urethral Closure Pressure Increases After Successful Adjustable Continence Therapy (ProACT) for Stress Urinary Incontinence After Radical Prostatectomy by Reuvers et al.

April 26, 2016

Image-empty-state.png

ProACT PMA Approved by USA FDA

Uromedica's ProACT Adjustable Continence Therapy for Men receives PMA Approval from the USA Food and Drug Administration (FDA)

November 24, 2015

Image-empty-state.png